Attacking anthrax.
Young
John A T
JA
McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, USA.
Collier
John R
JR
D000881:Anthrax / Q000382:microbiology / Q000401:mortality / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial; D000992:Antitoxins / Q000627:therapeutic use; D001408:Bacillus anthracis / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D001427:Bacterial Toxins; D023482:Bioterrorism; D005767:Gastrointestinal Diseases / Q000382:microbiology; D006801:Humans; D018000:Receptors, Peptide; D012141:Respiratory Tract Infections / Q000382:microbiology; D017192:Skin Diseases, Bacterial / Q000382:microbiology; D013171:Spores, Bacterial / Q000302:isolation & purification / Q000502:physiology
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D000992:Antitoxins; D001427:Bacterial Toxins; D018000:Receptors, Peptide; C030325:anthrax toxin; C070309:anthrax toxin receptors